Press Releases August 4, 2026 06:30 AM

Westlake Chemical Partners LP Announces Second Quarter 2026 Results

Westlake Chemical Partners LP reports Q2 2026 earnings with stable distributions and improved cash flows

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
WLKP

Westlake Chemical Partners LP announced its Q2 2026 financial results, reporting net income of $14.2 million and declaring its 48th consecutive quarterly distribution of $0.4714 per unit. The company benefited from higher third-party ethylene prices and stable cash flows due to an ethylene sales agreement with Westlake Corporation. Operating cash flows increased significantly compared to the prior year, driven by higher production and sales volumes and lower maintenance capital expenditures. The partnership also extended credit facility maturities to 2031 and maintained a healthy coverage ratio above 1.0x, supporting continued strong returns and predictable cash flows to unitholders.

Westlake Chemical Partners LP Announces Second Quarter 2026 Results
WLKP
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Declared 48th consecutive quarterly distribution of $0.4714 per unit, highlighting consistent returns to investors.
  • Second quarter net income steady at $14.2 million, with cash flows from operations significantly higher than prior year due to increased production and sales.
  • Ethylene sales agreement with Westlake Corporation ensures stability and predictability of cash flows.
  • Extension of senior unsecured revolving credit agreements to 2031 improves financial flexibility.
  • Declared quarterly distribution of $0.4714 per unit; 48th consecutive quarterly distribution

“Looking forward, we expect to continue to provide strong returns and predictable cash flows to our unitholders.”
“We were pleased with the Partnership's performance in the second quarter as we benefited from higher third-party ethylene prices and the continued stability…”
“Looking forward, we expect to continue to provide strong returns and predictable cash flows to our unitholders.”
“We were pleased with the Partnership's performance in the second quarter as we benefited from higher third-party ethylene prices and the continued stability…”
“Looking forward, we expect to continue to provide strong returns and predictable cash flows to our unitholders.”

HOUSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") today reported net income attributable to the Partnership in the second quarter of 2026 of $14.2 million, or $0.40 per limited partner unit, which was slightly below second quarter 2025 net income of $14.6 million. Cash flows from operating activities in the second quarter of 2026 were $129.8 million, an increase of $120.7 million compared to second quarter 2025 cash flows from operating activities of $9.1 million, primarily due to higher production and sales volume and lower maintenance capital expenditures as the result of the prior year's Petro 1 turnaround. For the three months ended June 30, 2026, MLP distributable cash flow was $17.6 million, an increase of $2.6 million compared to second quarter 2025 MLP distributable cash flow of $15.0 million. The increase in MLP distributable cash flow and associated trailing twelve-month coverage ratio of 1.04x was primarily due to higher production and sales volume and lower maintenance capital expenditures as a result of the prior year's Petro 1 turnaround.

Compared to the first quarter, second quarter 2026 net income attributable to the Partnership was unchanged at $14.2 million. Second quarter 2026 cash flows from operating activities of $129.8 million increased by $19.6 million due to working capital changes. Second quarter 2026 MLP distributable cash flow of $17.6 million decreased by $0.3 million compared to first quarter 2026 MLP distributable cash flow of $17.9 million due to higher maintenance capital expenditures.

"We were pleased with the Partnership's performance in the second quarter as we benefited from higher third-party ethylene prices and the continued stability of our cash flows due to the ethylene sales agreement with Westlake," said Jean-Marc Gilson, President and Chief Executive Officer. "Looking forward, we expect to continue to provide strong returns and predictable cash flows to our unitholders."

On July 8, 2026, both the Partnership and Westlake Chemical OpCo LP ("OpCo") entered into amendments to their respective senior unsecured revolving credit agreements with Westlake Corporation. These amendments extended the maturity dates of the facilities to July 2031.

On August 3, 2026, the Partnership announced that the Board of Directors of Westlake Chemical Partners GP LLC had approved a quarterly distribution for the second quarter of 2026 of $0.4714 per common unit to be payable on August 28, 2026 to unitholders of record as of August 13, 2026, representing the 48th consecutive quarterly distribution to our unitholders. MLP distributable cash flow provided trailing twelve-month coverage that was 1.04x the declared distributions for the second quarter of 2026, which was above the trailing twelve-month coverage ratio of 1.00x at the end of the first quarter. Since our IPO in July of 2014 our cumulative coverage ratio is approximately 1.05x.

OpCo's Ethylene Sales Agreement with Westlake is designed to provide for stable and predictable cash flows. The agreement provides that 95% of OpCo's ethylene production is sold to Westlake for a cash margin of $0.10 per pound, net of operating costs, maintenance capital expenditures and reserves for future turnaround expenditures.

The statements in this release and the related teleconference relating to matters that are not historical facts, such as those with respect to: our financing arrangements with Westlake; the timing and results of our turnaround activities, our outlook for third-party ethylene margins, the impact of the conflict in the Middle East on global demand for our products, our expectations regarding feedstock and energy costs, our ability to deliver value, returns, predictable cash flows and distributions to unitholders; our relationship with Westlake and the benefits of the ethylene sales agreement, are forward-looking statements. These forward-looking statements are subject to significant risks and uncertainties. Actual results could differ materially, based on factors including, but not limited to: operating difficulties or disruptions; the volume of ethylene that we are able to sell; the price at which we are able to sell ethylene; changes in the price and availability of feedstocks; changes in prevailing economic conditions; actions and commitments of Westlake, including determinations made pursuant to contractual arrangements with Westlake; the effects of legal proceedings; actions of third parties; inclement or hazardous weather conditions; environmental hazards; changes in laws and regulations (or the interpretation thereof); inability to acquire or maintain necessary permits; inability to obtain necessary production equipment or replacement parts; technical difficulties or failures; labor disputes; inability of our customers to take delivery; fires, explosions or other industrial accidents; political tension and conflict in the Middle East and elsewhere; the supply/demand balance for our products; and other risk factors. For more detailed information about the factors that could cause actual results to differ materially, please refer to the Partnership's Annual Report on Form 10-K for the year ended December 31, 2025, which was filed with the SEC in March 2026, and the Partnership’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, which was filed with the SEC in May 2026.

This release is intended to be a qualified notice under Treasury Regulation Section 1.1446-4(b). Brokers and nominees should treat one hundred percent (100.0%) of the Partnership's distributions to non-U.S. investors as being attributable to income that is effectively connected with a United States trade or business. Accordingly, the Partnership's distributions to non-U.S. investors are subject to federal income tax withholding at the highest applicable effective tax rate.

Use of Non-GAAP Financial Measures

This release makes reference to certain "non-GAAP" financial measures, such as MLP distributable cash flow, coverage ratio and EBITDA. For this purpose, a non-GAAP financial measure is generally defined by the Securities and Exchange Commission ("SEC") as a numerical measure of a registrant's historical or future financial performance, financial position or cash flows that (1) excludes amounts, or is subject to adjustments that have the effect of excluding amounts, that are included in the most directly comparable measure calculated and presented in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") in the statement of operations, balance sheet or statement of cash flows (or equivalent statements) of the registrant; or (2) includes amounts, or is subject to adjustments that have the effect of including amounts, that are excluded from the most directly comparable measure so calculated and presented. We report our financial results in accordance with U.S. GAAP, but believe that certain non-GAAP financial measures, such as MLP distributable cash flow, coverage ratio and EBITDA, provide useful supplemental information to investors regarding the underlying business trends and performance of our ongoing operations and are useful for period-over-period comparisons of such operations. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to, the financial measures prepared in accordance with U.S. GAAP. We define MLP distributable cash flow as distributable cash flow less distributable cash flow attributable to Westlake Corporation's noncontrolling interest in OpCo and distributions attributable to the incentive distribution rights holder. MLP distributable cash flow does not reflect changes in working capital balances. We define EBITDA as net income before interest expense, income taxes, depreciation and amortization. MLP distributable cash flow, coverage ratio and EBITDA are non-GAAP supplemental financial measures that management and external users of our consolidated financial statements, such as industry analysts, investors, lenders and rating agencies, may use to assess our operating performance as compared to other publicly traded partnerships, our ability to incur and service debt and fund capital expenditures and the viability of acquisitions and other capital expenditure projects and the returns on investment of various investment opportunities. Reconciliations of MLP distributable cash flow to net income and to net cash provided by operating activities and of EBITDA to net income, income from operations and net cash provided by operating activities can be found in the financial schedules at the end of this press release.

Westlake Chemical Partners LP

Westlake Chemical Partners is a limited partnership formed by Westlake Corporation to operate, acquire and develop ethylene production facilities and other qualified assets. Headquartered in Houston, the Partnership owns a 22.8% interest in Westlake Chemical OpCo LP. Westlake Chemical OpCo LP's assets consist of three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana, and an ethylene pipeline. For more information about Westlake Chemical Partners LP, please visit http://www.wlkpartners.com.

Westlake Chemical Partners LP Conference Call Information:

A conference call to discuss Westlake Chemical Partners' second quarter 2026 results will be held Tuesday, August 4, 2026 at 1:00 PM Eastern Time (12:00 PM Central Time). To access the conference call, please register at: https://register-conf.media-server.com/register/BI51826be52fb84f029203dae034f42aa3. A dial-in will be provided upon registration.

The conference call will also be available via webcast at: https://edge.media-server.com/mmc/p/ssbetq3b and the earnings release can be obtained via the Partnership web page at: https://investors.wlkpartners.com/corporate-profile/default.aspx.

WESTLAKE CHEMICAL PARTNERS LP ("WESTLAKE PARTNERS")
CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)  Three Months Ended June 30, Six Months Ended June 30,  2026   2025   2026   2025  (In thousands of dollars, except per unit data)Revenue       Net sales—Westlake Corporation ("Westlake")$        238,030  $        269,076  $        501,121  $        459,857 Net co-products, ethylene and other sales—third parties         59,070           28,043           101,654           74,891 Total net sales         297,100           297,119           602,775           534,748 Cost of sales         202,295           199,587           414,211           383,135 Gross profit         94,805           97,532           188,564           151,613 Selling, general and administrative expenses         7,494           6,300           14,684           13,774 Income from operations         87,311           91,232           173,880           137,839 Other income (expense)       Interest expense—Westlake         (5,119)          (5,907)          (10,204)          (11,444)Other income, net         348           675           696           2,021 Income before income taxes         82,540           86,000           164,372           128,416 Provision for income taxes         178           205           355           312 Net income         82,362           85,795           164,017           128,104 Less: Net income attributable to noncontrolling interest in Westlake Chemical OpCo LP ("OpCo")         68,124           71,237           135,610           108,598 Net income attributable to Westlake Partners$        14,238  $        14,558  $        28,407  $        19,506         Net income per limited partner unit attributable to Westlake Partners (basic and diluted)       Common units$        0.40  $        0.41  $        0.81  $        0.55         Distributions declared per unit$        0.4714  $        0.4714  $        0.9428  $        0.9428         MLP distributable cash flow$        17,636  $        15,007  $        35,522  $        19,721         Distributions declared       Limited partner units—publicly and privately held$        9,958  $        9,955  $        19,916  $        19,909 Limited partner units—Westlake         6,657           6,657           13,314           13,314 Total distributions declared$        16,615  $        16,612  $        33,230  $        33,223 EBITDA$        122,687  $        124,391  $        243,903  $        199,412 


WESTLAKE CHEMICAL PARTNERS LP
CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)  June 30,
2026 December 31,
2025 (In thousands of dollars)ASSETS   Current assets   Cash and cash equivalents$        49,321  $        44,269 Receivable under the Investment Management Agreement—Westlake         43,577           23,378 Accounts receivable, net—Westlake         39,464           63,571 Accounts receivable, net—third parties         21,602           9,113 Inventories         3,563           2,769 Prepaid expenses and other current assets         10           406 Total current assets         157,537           143,506 Property, plant and equipment, net         858,643           886,012 Other assets, net         201,168           227,015 Total assets$        1,217,348  $        1,256,533     LIABILITIES AND EQUITY   Current liabilities (accounts payable and accrued and other liabilities)$        45,768  $        51,301 Long-term debt payable to Westlake         399,674           399,674 Other liabilities         2,493           3,206 Total liabilities         447,935           454,181 Common unitholders—publicly and privately held         457,957           460,848 Common unitholder—Westlake         38,328           40,260 General partner—Westlake         (242,572)          (242,572)Total Westlake Partners partners' capital         253,713           258,536 Noncontrolling interest in OpCo         515,700           543,816 Total equity         769,413           802,352 Total liabilities and equity$        1,217,348  $        1,256,533 


WESTLAKE CHEMICAL PARTNERS LP
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
  Six Months Ended June 30,  2026   2025  (In thousands of dollars)Cash flows from operating activities   Net income$        164,017  $        128,104 Adjustments to reconcile net income to net cash provided by operating activities   Depreciation and amortization         69,327           59,552 Net loss on disposition and other         2,356           524 Other balance sheet changes         4,345           (133,328)Net cash provided by operating activities         240,045           54,852 Cash flows from investing activities   Additions to property, plant and equipment         (18,037)          (40,336)Investments with Westlake under the Investment Management Agreement         (20,000)          — Maturities of investments with Westlake under the Investment Management Agreement         —           90,000 Net cash provided by (used for) investing activities         (38,037)          49,664 Cash flows from financing activities   Proceeds from debt payable to Westlake         82,000           95,000 Repayment of debt payable to Westlake         (82,000)          (95,000)Distributions to noncontrolling interest retained in OpCo by Westlake         (163,726)          (93,031)Distributions to unitholders         (33,230)          (33,222)Net cash used for financing activities         (196,956)          (126,253)Net increase (decrease) in cash and cash equivalents         5,052           (21,737)Cash and cash equivalents at beginning of period         44,269           58,316 Cash and cash equivalents at end of period$        49,321  $        36,579 


WESTLAKE CHEMICAL PARTNERS LP
RECONCILIATION OF MLP DISTRIBUTABLE CASH FLOW TO NET INCOME

AND NET CASH PROVIDED BY OPERATING ACTIVITIES
(Unaudited)  Three Months Ended March 31,  Three Months Ended June 30, Six Months Ended June 30,  2026   2026   2025   2026   2025  (In thousands of dollars)Net cash provided by operating activities$        110,198  $        129,847  $        9,071  $        240,045  $        54,852 Changes in operating assets and liabilities and other         (28,543)          (47,485)          76,724           (76,028)          73,252 Net income         81,655           82,362           85,795           164,017           128,104 Add:         Depreciation, amortization and disposition of property, plant and equipment         34,360           37,155           32,872           71,515           60,043 Less:         Contribution to turnaround reserves         (10,232)          (10,305)          (10,396)          (20,537)          (18,018)Maintenance capital expenditures         (7,810)          (11,932)          (20,506)          (19,742)          (41,083)Distributable cash flow attributable to noncontrolling interest in OpCo         (80,087)          (79,644)          (72,758)          (159,731)          (109,325)MLP distributable cash flow$        17,886  $        17,636  $        15,007  $        35,522  $        19,721 


WESTLAKE CHEMICAL PARTNERS LP
RECONCILIATION OF EBITDA TO NET INCOME, INCOME FROM OPERATIONS AND NET CASH

PROVIDED BY OPERATING ACTIVITIES
(Unaudited)  Three Months Ended March 31,  Three Months Ended June 30, Six Months Ended June 30,  2026   2026   2025   2026   2025  (In thousands of dollars)Net cash provided by operating activities$        110,198  $        129,847  $        9,071  $        240,045  $        54,852 Changes in operating assets and liabilities and other         (28,543)          (47,485)          76,724           (76,028)          73,252 Net income         81,655           82,362           85,795           164,017           128,104 Less:         Other income, net         348           348           675           696           2,021 Interest expense—Westlake         (5,085)          (5,119)          (5,907)          (10,204)          (11,444)Provision for income taxes         (177)          (178)          (205)          (355)          (312)Income from operations         86,569           87,311           91,232           173,880           137,839 Add:         Depreciation and amortization         34,299           35,028           32,484           69,327           59,552 Other income, net         348           348           675           696           2,021 EBITDA$        121,216  $        122,687  $        124,391  $        243,903  $        199,412 


Contact—(713) 585-2900
Investors—Jonathan Baksht
Media—L. Benjamin Ederington


Risks

  • Operating risks include potential disruptions or difficulties affecting ethylene production and sales volumes.
  • Market risks related to fluctuations in ethylene prices and feedstock/energy costs affecting margins.
  • Geopolitical and regulatory risks, including political tensions in the Middle East impacting global demand and changes in laws or permitting that could affect operations.

More from Press Releases

YY Group Acquires 95% Stake in Profitable Singapore-Incorporated Distributor Aug 4, 2026 Palvella Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update Aug 4, 2026 Zevra Therapeutics to Present at the Canaccord Genuity Annual Growth Conference Aug 4, 2026 Harmony Biosciences Announces Record Q2 2026 Revenue and Shares Initial Clinical Data for Its Orexin-2 Agonist BP-205 Reinforcing Potential Best-in-Class Profile Aug 4, 2026 Creative Realities, Inc. Announces Second Quarter 2026 Earnings Release Date and Conference Call Information Aug 4, 2026